Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | EGFR | P00533 | 1/20 | 0.72 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | RAB9A | P51151 | 3/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.63 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.63 |
| ▸ | CASP3 | P42574 | 1/20 | 0.63 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.63 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.63 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 4/20 | 0.59 |
| ▸ | CA2 | P00918 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | CA12 | O43570 | 2/20 | 0.59 |
| ▸ | CA9 | Q16790 | 2/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL28493400 | 0.98 | TSHR (0.72) | TSHREGFRPTPN1MAPTRAB9A | |
| Phosphine SCHEMBL28496548 | 0.98 | TSHR (0.72) | TSHREGFRPTPN1MAPTRAB9A | |
| SCHEMBL28495999 | 0.96 | EGFR (0.73) | TSHREGFRPTPN1MAPTRAB9A | |
| SCHEMBL28931930 | 0.96 | EGFR (0.73) | TSHREGFRPTPN1MAPTRAB9A | |
| Trimethylammonium SCHEMBL27715481 | 0.94 | TSHR (0.67) | TSHREGFRPTPN1MAPTRAB9A | |
| Biphenyl SCHEMBL28575404 | 0.93 | TSHR (0.86) | TSHREGFRPTPN1MAPTRAB9A | |
| SCHEMBL27589486 | 0.93 | TSHR (0.64) | TSHREGFRPTPN1MAPTRAB9A | |
| Methyl Benzoate SCHEMBL28140701 | 0.92 | TSHR (0.70) | TSHREGFRPTPN1MAPTRAB9A | |
| SCHEMBL19387238 | 0.91 | CA1 (0.70) | TSHREGFRPTPN1MAPTRAB9A | |
| Biphenyl Dimethyl Dicarboxylate SCHEMBL68521 | 0.91 | CA1 (0.70) | TSHREGFRPTPN1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 419 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119912334-A | Preparation method of p-pentoxy-terphenyl methyl formate and anidulafungin side chain | 广东新达瑞生物科技有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119661322-A | Synthesis method of 4-diphenyl methanol | 河北科技大学 | 2025-03-21 | — | — | CN | claimed |
| CN-118580198-A | Dicarboxylic acid ligand containing benzothiadiazole functional group for preparing metal organic framework and preparation method thereof | 江西理工大学 | 2024-09-03 | — | — | CN | claimed |
| WO-2023212597-A1 | CARBON DIOXIDE CAPTURE AND UTILIZATION AS A CLEAN FEEDSTOCK | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2023-11-02 | — | — | WO | claimed |
| CN-115433204-A | Synthetic method and application of spiro-expansible monomer with multi-benzene ring structure | 深圳市安伯斯科技有限公司 | 2022-12-06 | — | — | CN | claimed |
| US-20220185785-A1 | INHIBITORS OF CD40-CD154 BINDING | TONIX Pharmaceuticals Holding Corp (US) | 2022-06-16 | — | — | US | claimed |
| CN-107540848-B | Preparation and application of efficient heterogeneous hydrogen bond donor MOF catalyst | 合肥工业大学 | 2020-11-24 | — | — | CN | claimed |
| CN-106117048-A | A kind of method synthesizing biphenyl 4 methyl formate | 辽宁石油化工大学 | 2016-11-16 | — | — | CN | claimed |
| CN-104364246-A | Piperidine derivatives useful as GPR119 agonists | TOYOTA MOTOR CO LTD | 2015-02-18 | — | — | CN | claimed |
| CN-102356068-B | 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds | HOFFMANN LA ROCHE | 2014-04-23 | — | — | CN | claimed |
| US-5049496-A | Method for microbiologically hydroxylating biphenyl and terphenyl compounds | GENERAL ELECTRIC COMPANY (US) | 1991-09-17 | — | — | US | claimed |
| WO-2026103887-A1 | PROLINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 北京康辰药业股份有限公司 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026098560-A2 | BENZENE-CONTAINING POLYCYCLIC DERIVATIVE MODULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翰森生物医药科技有限公司 | 2026-05-15 | — | — | WO | disclosed |
| US-12559455-B2 | Compound as a UBR box domain ligand | AUTOTAC INC. (KR) | 2026-02-24 | — | — | US | disclosed |
| US-20250188626-A1 | CARBON DIOXIDE CAPTURE AND UTILIZATION AS A CLEAN FEEDSTOCK | UNIV MICHIGAN TECH (US) | 2025-06-12 | — | — | US | disclosed |
| US-3980642-A | 15-Substitute D-ω-pentanorprostaglandins | PFIZER INC. (US) | 1976-09-14 | — | — | US | disclosed |
| US-3974213-A | 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins | PFIZER INC. (US) | 1976-08-10 | — | — | US | disclosed |
| US-3971826-A | 15-Substituted-ω-pentanorprostaglandins | PFIZER INC. (US) | 1976-07-27 | — | — | US | disclosed |
| US-3956284-A | INCREASED TISSUE SPECIFITY OF ACTION | PFIZER INC. (US) | 1976-05-11 | — | — | US | disclosed |
| US-3953466-A | TETRAZOYL DERIVATIVES OF PROSTAGLANDINS | PFIZER INC. (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220185785-A1 | INHIBITORS OF CD40-CD154 BINDING | CD40LG, CD40, CD4 | TSHR 908/4885EGFR 2982/4885PTPN1 518/4885 |
| US-12559455-B2 | Compound as a UBR box domain ligand | UBR4, UBTF, UBQLN1 | TSHR 1240/4885EGFR 1402/4885PTPN1 1196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.